DermTopic: Psoriasis

Filter Your Results

 

News

 

Ortho Dermatologics’ DUOBRII Improves Psoriasis Symptoms A…

DUOBRII (halobetasol propionate and tazarotene) (IDP-118) lotion demonstrated significant superiority over vehicle as ea…

GlobalData: Sun Pharma’s Ilumya To Face Strong Competition…

It’s a tough road ahead for Sun Pharma’s newly approved Ilumya, according to a new report from a href="http:…

Escalier Biosciences Closes Financing, Focuses on Psoriasis

Escalier Biosciences BV, a privately held biopharmaceutical company, this month closed $19 million Series B fi…

DermWireTV: ABD Eyes Mohs Certification, Sun's Ilumya Approv…

The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialt…

DermWire.com

Skin of Color Society Reports Banner Year

Kudos to the Skin of Color Society (SOCS) for a banner year. At its recent annual business meeting held in conjunctio…

Understanding Psoriasis Comorbidities

Psoriasis is more than just a skin condition, and it can travel with bone fractures and other immune-mediated diseases. …

Ronald Prussick, MD

FDA Approves Label Update for Cimzia Addressing Low Risk of …

The FDA has approved a label update that includes pharmacokinetic data showing negligible to low transf…

Sun Pharma: FDA Approves Ilumya for Adult Psoriasis

The FDA has approved Ilumya™ (tildrakizumab-asmn) from Sun Pharma for the treatment of adults with moderate-to-sev…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.